XML 28 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Based Compensation
3 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Based Compensation
Stock Based Compensation 
 The Company's 2008 Stock Incentive Plan ("2008 Plan") was adopted by the Board of Directors of the Company on February 19, 2008, and approved by shareholders on April 22, 2008, at the Company's 2008 Annual Meeting of Shareholders.  The 2008 Plan provided for the granting of restricted stock awards and incentive and non-statutory options to employees and directors on a periodic basis, at the discretion of the Board of Directors or a Board designated committee.  The 2008 Plan authorized the issuance of up to 500,000 shares of common stock. The 2008 Plan replaced the Company's stock option plan that was approved by the shareholders at the 1997 Annual Meeting, which expired in 2006. The 2008 Plan terminated in February 2018. The Board will be proposing a new stock based compensation plan for shareholder approval at the upcoming 2018 Annual Meeting (the 2018 Equity Compensation Plan).
Stock Options
Accounting guidance requires that compensation cost relating to share-based payment transactions be recognized in the financial statements with measurement based upon the fair value of the equity or liability instruments issued.
A summary of stock option transactions for the three months ended March 31, 2018 is as follows:
 
Option
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual Term
 
Aggregate
Intrinsic
Value
($000)
Outstanding at December 31, 2017
50,985

 
$
24.09

 
 
 
 
Acquired in acquisition

 

 
 
 
 
Granted

 

 
 
 
 
Exercised
(3,300
)
 
25.76

 
 
 
 
Forfeited

 

 
 
 
 
Expired
(1,650
)
 
33.33

 
 
 
 
Outstanding at March 31, 2018
46,035

 
$
23.64

 
0.59 years
 
$
643

Exercisable at March 31, 2018
46,035

 
$
23.64

 
0.59 years
 
$
643


The fair value of options is estimated at the date of grant using the Black-Scholes option pricing model and expensed over the options' vesting period.  No stock options have been granted since 2009. As of March 31, 2018, there were no unrecognized compensation expenses related to nonvested stock option grants.
Restricted Stock
The Company from time-to-time grants shares of restricted stock to key employees and non-employee directors.  These awards help align the interests of these employees and directors with the interests of the shareholders of the Company by providing economic value directly related to increases in the value of the Company's common stock.  The value of the stock awarded is established as the fair value of the stock at the time of the grant.  The Company recognizes expense, equal to the total value of such awards, ratably over the vesting period of the stock grants. The majority of the restricted stock granted cliff vests at the end of a 36 month period beginning on the date of the grant. The remainder vests one-third each year beginning on the date of the grant. Nonvested restricted stock activity for the three months ended March 31, 2018 is summarized in the following table.
Restricted Stock
Shares
 
Weighted Average Grant Date Value
Nonvested at December 31, 2017
46,501

 
$
26.28

Granted
18,192

 
39.52

Vested
(10,101
)
 
21.62

Forfeited
(483
)
 
34.70

Nonvested at March 31, 2018
54,109

 
$
31.53


As of March 31, 2018 and December 31, 2017, there was $1,110,000 and $538,000, respectively, in unrecognized compensation cost related to nonvested restricted stock granted under the 2008 Plan.  The weighted average period over which this cost is expected to be recognized is 1.71 years.  The share based compensation expense for nonvested restricted stock was $147,000 and $192,000 during the first three months of 2018 and 2017, respectively. 
The Company offers its outside directors alternatives with respect to director compensation. For 2018, the regular quarterly board retainer will be received in the form of shares of immediately vested, but restricted stock with a market value of $7,500. Monthly meeting fees can be received as $725 per meeting in cash or $900 in immediately vested, but restricted stock.  Only outside directors receive board fees. The Company issued 3,477 and 3,251 shares and recognized share based compensation expense of $130,000 and $117,000 during the first three months of 2018 and 2017, respectively.